Scientists say they have identified a self-destruct button within EBV-associated gastric cancer, and also figured out how to press that self-destruct button.
The study has discovered specific changes in our DNA that increase the risk of developing epilepsy, advancing our knowledge of why epilepsy develops.
The genes of the mitochondria, the energy producers of our cells, can be negatively impacted by SARS-CoV-2, leading to dysfunction in multiple organs beyond the lungs.
The mechanism that repairs our skin cells' DNA takes precedence over all other systems in the cell, temporarily inhibiting the pigmentation mechanism.
Computational biology company PrecisionLife has identified 73 genes that are highly associated with severe and fatigue-dominant forms of long COVID.
Researchers developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.
The PrOSPeCT program will give 23,000 cancer patients free access to genomic profiling and matching to the best advanced precision treatments available locally, including early-stage clinical trials.
The p38 protein regulates a wide variety of cellular functions and is related to diseases such as chronic inflammation, immunological disorders and cancer.
Researchers have unveiled an astounding array of unexplored protein folds, expanding our understanding and uncovering the depth of the protein universe.
MGI promised to take genomics to the next level with its extensive product portfolio and one-stop-shop solutions at the XXIIIrd International Congress of Genetics.
Researchers have invented a new way to map specific DNA markings called 5-methylcytosine (5mC), which regulate gene expression and have key roles in health and disease.
A research team has identified a new rare genetic syndrome that causes intellectual disability and differences of sex development (DSD) in children.
A programmable gene editing technology called prime editing can correct the mutation that causes sickle cell disease, in a potentially curative approach.
A preclinical study using stem cells to produce progenitor photoreceptor cells and then transplanting these into experimental models of damaged retinas has resulted in significant vision recovery.
Researchers have developed an optimised genome-editing method that reduces mutations, opening the door to more effective treatment of genetic diseases.